Fennec Pharmaceuticals Correlations
FENC Stock | USD 6.60 0.07 1.05% |
The current 90-days correlation between Fennec Pharmaceuticals and Molecular Partners AG is 0.09 (i.e., Significant diversification). The correlation of Fennec Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Fennec Pharmaceuticals Correlation With Market
Weak diversification
The correlation between Fennec Pharmaceuticals and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Fennec |
Moving together with Fennec Stock
0.72 | LUCD | Lucid Diagnostics | PairCorr |
0.76 | WM | Waste Management | PairCorr |
0.74 | GE | GE Aerospace | PairCorr |
0.67 | PG | Procter Gamble | PairCorr |
0.7 | CSCO | Cisco Systems | PairCorr |
0.72 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.65 | MMM | 3M Company | PairCorr |
0.8 | T | ATT Inc Sell-off Trend | PairCorr |
0.79 | IBM | International Business | PairCorr |
Moving against Fennec Stock
0.71 | SCLX | Scilex Holding | PairCorr |
0.54 | ASMB | Assembly Biosciences Earnings Call Tomorrow | PairCorr |
0.49 | CDIO | Cardio Diagnostics | PairCorr |
0.48 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.42 | ELVN | Enliven Therapeutics | PairCorr |
0.41 | CMND | Clearmind Medicine Common | PairCorr |
0.4 | CDIOW | Cardio Diagnostics | PairCorr |
0.66 | MRK | Merck Company | PairCorr |
0.55 | MSFT | Microsoft Aggressive Push | PairCorr |
0.53 | CAT | Caterpillar | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Fennec Stock performing well and Fennec Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fennec Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MOLN | 2.71 | (0.34) | 0.00 | (0.21) | 0.00 | 7.84 | 20.58 | |||
MNOV | 2.26 | (0.47) | 0.00 | (0.71) | 0.00 | 5.35 | 16.27 | |||
ANEB | 5.66 | 0.65 | 0.11 | 0.50 | 5.59 | 19.58 | 48.29 | |||
CSBR | 4.25 | 0.87 | 0.17 | 0.55 | 4.35 | 9.97 | 29.24 | |||
CYT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
KROS | 2.61 | (0.74) | 0.00 | (17.53) | 0.00 | 4.41 | 17.79 | |||
JANX | 2.92 | (0.87) | 0.00 | (0.59) | 0.00 | 8.08 | 20.17 | |||
EWTX | 2.65 | (0.40) | 0.00 | (0.31) | 0.00 | 4.89 | 17.09 | |||
HRMY | 1.99 | 0.12 | 0.04 | 0.10 | 2.97 | 4.36 | 17.63 |
Fennec Pharmaceuticals Corporate Management
Mark Meier | VP Commercial | Profile | |
Christiana MBA | Chief Officer | Profile | |
Mark Gowland | Controller | Profile | |
Terry Evans | Chief Officer | Profile | |
Robert Andrade | Chief Officer | Profile |